Zusammenfassung
Wie eine Volumentherapie bei akuter Hämorrhagie durchgeführt werden soll, wird nach wie vor kontrovers diskutiert. Obwohl die forcierte Gabe von Kristalloiden und Kolloiden lange Zeit praktiziert wurde und auch noch praktiziert wird, gibt es heute gute Argumente dafür, dass eine zurückhaltende Infusion von Kristalloiden zunächst ausreichend sein kann. Allerdings sollte 0,9 %ige NaCl-Lösung als Volumenersatz nicht mehr verabreicht werden. Für eine zurückhaltende Volumentherapie spricht, dass keine großen prospektiven und randomisierten Studien existieren, die bewiesen hätten, dass die forcierte Gabe von Volumenersatzmitteln die Überlebensrate verbessert. Dass bislang kein positiver Effekt beobachtet werden konnte, wird damit erklärt, dass die Volumentherapie selbst eine Blutung durch einen Blutdruckanstieg und eine Dilutionskoagulopathie verstärken soll. Gleichwohl empfehlen nationale und internationale Leitlinien, dass ein Volumenersatz spätestens dann verabreicht werden soll, wenn die Hämodynamik unter einer Blutung instabil wird. Es muss auch bedacht werden, dass eine „damage control resuscitation“ per se weder eine bereits reduzierte Gewebeperfusion noch die Hämostase verbessert. Im akuten und ggf. schnell progredienten Volumenmangelschock können Kolloide den Kristalloiden unter dem Aspekt einer hämodynamischen Stabilisierung überlegen sein. Hydroxyethylstärke (HES) der 3. und 4. Generation ist bei gegebener Indikation und unter Beachtung der Höchstdosierung sicher. Werden Volumenersatzmittel unter ständiger Reevaluation der Parameter, die das Sauerstoffangebot beeinflussen, verabreicht, sollte das Ziel sein, so wenig zu infundieren, dass es nicht zu unerwünschten Effekten kommt, aber so viel, dass die Versorgung des Gewebes mit Sauerstoff und das Überleben der Patienten sichergestellt sind.
Abstract
How fluid resuscitation has to be performed for acute hemorrhage situations is still controversially discussed. Although the forced administration of crystalloids and colloids has been and still is practiced, nowadays there are good arguments that a cautious infusion of crystalloids may be initially sufficient. Saline should no longer be used for fluid resuscitation. The main argument for cautious fluid resuscitation is that no large prospective randomized clinical trials exist which have provided evidence of improved survival when fluid resuscitation is applied in an aggressive manner. The explanation that no positive effect has so far been observed is that fluid resuscitation is thought to boost bleeding by increasing blood pressure and dilutional coagulopathy. Nevertheless, national and international guidelines recommend that fluid resuscitation should be applied at the latest when hemorrhage causes hemodynamic instability. Consideration should be given to the fact that damage control resuscitation per se will neither improve already reduced tissue perfusion nor hemostasis. In acute and possibly rapidly progressing hypovolemic shock, colloids can be used. The third and fourth generations of hydroxyethyl starch (HES) are safe and effective if used correctly and within prescribed limits. If fluid resuscitation is applied with ongoing re-evaluation of the parameters which determine oxygen supply, it should be possible to keep fluid resuscitation restricted without causing undesirable side effects and also to administer a sufficient quantity so that survival of patients is ensured.
Literatur
Adams HA (Federführender Autor) (2005) Sprecher der IAG Schock der DIVI. Zur Diagnostik und Therapie der Schockformen – Empfehlungen der Interdisziplinären Arbeitsgruppe Schock der DIVI – Teil II Hypovolämischer Schock. Anasthesiol Intensivmed 4:111–124
Annane D, Siami S, Jaber S et al (2013) Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA 310(17):1809–1817
Appelman MH, Barneveld LJ van, Romijn JW et al (2011) The impact of balanced hydroxylethyl starch cardiopulmonary bypass priming solution on the fibrin part of clot formation: ex vivo rotation thromboelastometry. Perfusion 26(3):175–180
Balogh Z, McKinley BA, Cocanour CS et al (2003) Supranormal trauma resuscitation causes more cases of abdominal compartment syndrome. Arch Surg 138(6):637–642
Barriot P, Riou B (1987) Hemorrhagic shock with paradoxical bradycardia. Intensive Care Med 13:203–217
Battison C, Andrews PJ, Graham C, Petty T (2005) Randomized, controlled trial on the effect of a 20 % mannitol solution and a 7.5 % saline/6 % dextran solution on increased intracranial pressure after brain injury. Crit Care Med 33(1):196–202
Becker BF, Chappell D, Jacob M (2010) Endothelial glycocalyx and coronary vascular permeability: the fringe benefit. Basic Res Cardiol 105(6):687–701
Bickell WH, Wall MJ Jr, Pepe PE et al (1994) Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 331(17):1105–1109
Biffl WL, Moore EE, Burch JM et al (2001) Secondary abdominal compartment syndrome is a highly lethal event. Am J Surg 182(6):645–648
Bishop MH, Shoemaker WC, Appel PL et al (1995) Prospective, randomized trial of survivor values of cardiac index, oxygen delivery, and oxygen consumption as resuscitation endpoints in severe trauma. J Trauma 38(5):780–787
Boerema I, Meyne NG, Brummelkamp WH et al (1959) Life without blood (a study of influence of high atmospheric pressure and hypothermia on dilution of blood). J Cardiovasc Surg 13:133–146
Boerema I (1965) The use of hyperbaric oxygen. Am Heart J 69(3):289–291
Bolliger D, Görlinger K, Tanaka KA (2010) Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology 113(5):1205–1219
Brasel KJ, Guse C, Gentilello LM, Nirula R (2007) Heart rate: is it truly a vital sign? J Trauma 62:812–817
Brunkhorst FM, Engel C, Bloos F et al (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358(2):125–139
Brunkhorst FM, Gastmeier P, Kern W et al (2010) Prävention, Diagnose, Therapie und Nachsorge der Sepsis. 1. Revision der S-2k Leitlinien der Deutschen Sepsis-Gesellschaft e. V. (DSG) und der Deutschen Interdisziplinären Vereinigung für Intensiv- und Notfallmedizin (DIVI). Internist 51(7):925–932
Bulger EM, Jurkovich GJ, Nathens AB et al (2008) Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial. Arch Surg 143(2):139–148
Bunn F, Roberts I, Tasker R, Akpa E (2004) Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 3:CD002045
Bunn F, Trivedi D, Ashraf S (2011) Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev 16(3):CD001319
Campagna J, Carter C (2003) Clinical relevance of the Bezold-Jarisch reflex. Anesthesiology 98:1250–1260
Carl M, Alms A, Braun J et al (2010) S3 guidelines for intensive care in cardiac surgery patients: hemodynamic monitoring and cardiocirculary system. Ger Med Sci 8:Doc12
Chappell D, Jacob M, Becker BF et al (2008) Expedition Glykokalyx. Ein neu entdecktes „great barrier reef“. Anaesthesist 57(10):959–969
Chappell D, Jacob M, Hofmann-Kiefer K et al (2008) A rational approach to perioperative fluid therapy. Anesthesiology 109:723–740
Chappell D, Jacob M (2013) Hydroxyethyl starch – the important of being earnest. Scand J Trauma Resusc Emerg Med 21:61
Chesnut RM, Marshall LF, Klauber MR et al (1993) The role of secondary brain injury in determining outcome from severe head injury. J Trauma 34(2):216–222
Cooper DJ, Myles PS, McDermott FT et al (2004) Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: a randomized controlled trial. JAMA 291(11):1350–1357
Cotton BA, Jerome R, Collier BR et al (2009) Guidelines for prehospital fluid resuscitation in the injured patient. J Trauma 67(2):389–402
Dalrymple-Hay M, Aitchison R, Collins P et al (1992) Hydroxyethyl starch induced acquired von Willebrand’s disease. Clin Lab Haematol 4:209–211
Damon L, Adams M, Stricker RB, Ries C (1987) Intracranial bleeding during treatment with hydroxyethyl starch. N Engl J Med 317:964–965
De Jonge E, Levi M, Berends F et al (1998) Impaired hemostasis by intravenous administration of a gelatin-based plasma expander in human subjects. Thromb Haemost 79(2):286–290
De Jonge E, Levi M (2001) Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med 29(6):1261–1267
Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39(2):165–228
Demetriades D, Chan LS, Bhasin P et al (1998) Relative bradycardia in patients with traumatic hypotension. J Trauma 45:534–549
Deusch E, Thaler U, Kozek-Langenecker SA (2004) The effects of high molecular weight hydroxyethyl starch solutions on platelets. Anesth Analg 99(3):665–668
Deutsche Gesellschaft für Unfallchirurgie (Hrsg) (2011) S-3 Leitlinie Polytrauma/Schwerverletzten Behandlung. AWMF Register 012/019. 01.07.2011. http://www.awmf.org/leitlinien/detail/ll/012-019.html
Donati A, Loggi S, Preiser JC et al (2007) Goal-directed intraoperative therapy reduces morbidity and length of hospital stay in high-risk surgical patients. Chest 132(6):1817–1824
Dorje P, Adhikary G, Tempe DK (2000) Avoiding iatrogenic hyperchloremic acidosis – call for a new crystalloid fluid. Anesthesiology 92(2):625–626
Dutton RP, Mackenzie CF, Scalea TM (2002) Hypotensive resuscitation during active hemorrhage: impact on in-hospital mortality. J Trauma 52(6):1141–1146
Eastridge BJ, Salinas J, McManus JG et al (2007) Hypotension begins at 110 mmHg: redefining „hypotension“ with data. J Trauma 63:291–299
Entholzner EK, Mielke LL, Calatzis AN et al (2000) Coagulation effects of a recently developed hydroxyethyl starch (HES 130/0.4) compared to hydroxyethyl starches with higher molecular weight. Acta Anaesthesiol Scand 44(9):1116–1121
Falk JL, Rackow E, Astiz M, Weil MH (1988) Fluid resuscitation in shock. J Cardiothor Anesth 2(6):33–38
Finfer S, Bellomo R, Boyce N et al (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. SAFE Study Investigators. N Engl J Med 350(22):2247–2256
Fishman AP (1973) Shock lung: a distinctive nonentity. Circulation 47(5):921–923
Fries D, Innerhofer P, Perger P et al (2010) Coagulation management in trauma-related massive bleeding. – Recommendations of the Task Force for Coagulation (AGPG) of the Austrian Society of Anesthesiology, Resucitation and Intensive Care Medicine (OGARI). Anasthesiol Intensivmed Notfallmed Schmerzther 45(9):552–561
Fuller G, Hasler RM, Mealing N et al (2014) The association between admission systolic blood pressure and mortality in significant traumatic brain injury: a multi-centre cohort study. Injury 45(3):612–617
Futier E, Vallet B (2010) Inotropes in goal-directed therapy: do we need „goals“? Crit Care 14(5):1001
Guidet B, Martinet O, Boulain T et al (2012) Assessment of hemodynamic efficacy and safety of 6 % hydroxyethylstarch 130/0.4 vs. 0.9 % NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Crit Care 16(3):R94
Gutierrez G, Reines HD, Wulf-Gutierrez ME (2004) Clinical review: hemorrhagic shock. Crit Care 8(5):373–381
Hamilton-Davies C, Mythen MG, Salmon JB et al (1997) Comparison of commonly used clinical indicators of hypovolaemia with gastrointestinal tonometry. Intensive Care Med 23(3):276–281
Hampton DA, Fabricant LJ, Differding J et al (2013) Prehospital intravenous fluid is associated with increased survival in trauma patients. J Trauma Acute Care Surg 75(1 Suppl 1):S9–S15
Hartog CS, Bauer M, Reinhart K (2011) The efficacy and safety of colloid resuscitation in the critically ill. Anesth Analg 112(1):156–164
Hasler RM, Nuesch E, Jüni P et al (2011) Systolic blood pressure below 110 mmHg is associated with increased mortality in blunt major trauma patients: multicentre cohort study. Resuscitation 82:1202–1207
Helm M, Hauke J, Kohler J, Lampl L (2013) Das Konzept der „small volume resuscitation“ im Rahmen des präklinischen Traumamanagements. Unfallchirurg 116:326–331
Holcomb JB, Jenkins D, Rhee P et al (2007) Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma 62(2):307–310
Hussmann B, Taeger G, Lefering R et al (2011) TraumaRegister der Deutschen Gesellschaft für Unfallchirurgie. Letalität und Outcome beim Mehrfachverletzten nach schwerem Abdominal- und Beckentrauma. Einfluss der präklinischen Volumengabe – eine Auswertung von 604 Patienten des TraumaRegisters der DGU. Unfallchirurg 114(8):705–712
Innerhofer P, Fries D, Margreiter J et al (2002) The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesth Analg 95(4):858–865
Jacob M, Rehm M, Orth V et al (2003) Exact measurement of the volume effect of 6 % hydroxyethyl starch 130/0.4 (Voluven) during acute preoperative normovolemic hemodilution. Anaesthesist 52:896–904
Jacob M, Bruegger D, Rehm M et al (2006) Contrasting effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability. Anesthesiology 104(6):1223–1231
Jacob M, Chappell D, Rehm M (2007) Clinical update: perioperative fluid management. Lancet 369(9578):1984–1986
Jacob M, Bruegger D, Rehm M et al (2007) The endothelial glycocalyx affords compatibility of Starling’s principle and high cardiac interstitial albumin levels. Cardiovasc Res 73(3):575–586
Jacob M, Chapell D (2009) Mythen und Fakten der perioperativen Infusionstherapie. Anasth Intensivmed 50:358–376
Jacob M, Chappell D, Rehm M (2009) The ‚third space’-fact or fiction? Best Pract Res Clin Anaesthesiol 23(2):145–157
Jaeger M, Dengl M, Meixensberger J, Schuhmann MU (2010) Effects of cerebrovascular pressure reactivity-guided optimization of cerebral perfusion pressure on brain tissue oxygenation after traumatic brain injury. Crit Care Med 38(5):1343–1347
James MF, Michell WL, Joubert IA et al (2011) Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). Br J Anaesth 107(5):693–702
Jones PA, Andrews PJ, Midgley S et al (1994) Measuring the burden of secondary insults in head-injured patients during intensive care. J Neurosurg Anesthesiol 6(1):4–14
Khan S, Brohi K, Chana M et al (2014) Hemostatic resuscitation is neither hemostatic nor resuscitative in trauma hemorrhage. J Trauma Acute Care Surg 76(3):561–567
Kozek-Langenecker SA, Jungheinrich C, Sauermann W, Van der Linden P (2008) The effects of hydroxyethyl starch 130/0.4 (6 %) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials. Anesth Analg 107(2):382–390
Krappweis J, Diesinger C (2013) Hydroxyethylstärke (HES): Start eines europäischen Risikobewertungsverfahrens. BfArM Bulletin Arzneimittelsicherheit 1:3–6
Kwan I, Bunn F, Roberts I, WHO Pre-Hospital Trauma Care Steering Committee (2009) Timing and volume of fluid administration for patients with bleeding. Cochrane Database Syst Rev 3:CD002245
Lamke LO, Liljedahl SO (1976) Plasma volume changes after infusion of various plasma expanders. Resuscitation 5(2):93–102
Laubenthal H (1997) BSE und Heparin- bzw. Gelatinepräparate. Anaesthesist 46:253–254
Laxenaire MC, Charpentier C, Feldmann L (1994) Réactions anaphylactoides aux substituts colloidaux du plasma: incidence de risque, mécanismes. Ann Fr Anesth Reanim 13:301–310
Levi M, Jonge ED (2007) Clinical relevance of the effects of plasma expanders on coagulation. Semin Thromb Hemost 33(8):810–815
Ley EJ, Salim A, Kohanzadeh S et al (2009) Relative bradycardia in hypotensive trauma patients: a reappraisal. J Trauma 67(5):1051–1054
Lieberman JA, Weiskopf RB, Kelley SD et al (2000) Critical oxygen delivery in conscious humans is less than 7.3 ml O2 × kg(− 1) × min(− 1). Anesthesiology 92(2):407–413
Lier H, Krep H, Schöchl H (2009) Coagulation management in the treatment of multiple trauma. Anaesthesist 58(10):1010–1026
Little RA, Krikman E, Dricoll P et al (1995) Preventable deaths after injury: why are the traditional ‚vital‘ signs poor indicators of blood loss? J Accid Emerg Med 12(1):1–14
Lobo DN, Stanga Z, Aloysius MM et al (2010) Effect of volume loading with 1 liter intravenous infusions of 0.9 % saline, 4 % succinylated gelatine (Gelofusine) and 6 % hydroxyethyl starch (Voluven) on blood volume and endocrine responses: a randomized, three-way crossover study in healthy volunteers. Crit Care Med 38(2):464–470
Lobo SM, Salgado PF, Castillo VG et al (2000) Effects of maximizing oxygen delivery on morbidity and mortality in high-risk surgical patients. Crit Care Med 28(10):3396–3404
Mackey DC, Cerpenter RL, Thompson GE et al (1989) Bradycardia and asystole during spinal anaesthesia: a report of three cases without morbidity. Anesthesiology 70:866–868
Mahmood A, Gosling P, Vohra RK (2007) Randomized clinical trial comparing the effects on renal function of hydroxyethyl starch or gelatine during aortic aneurysm surgery. Br J Surg 94(4):427–433
Maier S, Holz-Hölzl C, Pajk W et al (2009) Microcirculatory parameters after isotonic and hypertonic colloidal fluid resuscitation in acute hemorrhagic shock. J Trauma 66(2):337–345
Manley G, Knudsen MM, Morabito D et al (2001) Hypotension, hypoxia, and head injury: frequency, duration and consequences. Arch Surg 136:1118–1123
Mardel SN, Saunders FM, Allen H et al (1998) Reduced quality of clot formation with gelatin-based plasma substitutes. Br J Anaesth 80(2):204–207
Mittermayr M, Streif W, Haas T et al (2007) Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesth Analg 105(4):905–917
Mittermayr M, Streif W, Haas T et al (2008) Effects of colloid and crystalloid solutions on endogenous activation of fibrinolysis and resistance of polymerized fibrin to recombinant tissue plasminogen activator added ex vivo. Br J Anaesth 100(3):307–314
Morrison LJ, Baker AJ, Rhind SG et al (2011) The Toronto prehospital hypertonic resuscitation - head injury and multiorgan dysfunction trial: feasibility study of a randomized controlled trial. J Crit Care 26(4):363–372
Myburgh JA, Finfer S, Bellomo R et al (2012) Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 367(20):1901–1911
Myburgh JA, Finfer S, Billot L, CHEST Investigators (2013) Hydroxyethyl starch or saline in intensive care. N Engl J Med 368(8):775
Neff TA, Doelberg M, Jungheinrich C et al (2003) Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury. Anesth Analg 96(5):1453–1459
Ogilvie MP, Pereira BM, McKenney MG et al (2010) First report on safety and efficacy of hetastarch solution for initial fluid resuscitation at a level 1 trauma center. J Am Coll Surg 210(5):870–880, 880–882
Perel P, Roberts I (2011) Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 3:CD000567
Perner A, Haase N, Guttormsen AB et al (2012) Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med 367(2):124–134
Pinsky MR (2007) Hemodynamic evaluation and monitoring in the ICU. Chest 132(6):2020–2029
Price HL, Deutsch S, Marshall BE et al (1966) Hemodynamic and metabolic effects of hemorrhage in man, with particular reference to the splanchnic circulation. Circ Res 18(5):469–474
Pries AR, Secomb TW, Gaehtgens P (2000) The endothelial surface layer. Pflugers Arch 440(5):653–666
Raum MR, Waydhas C (2009) Präklinische Volumentherapie bei Trauma. Notfall Rettungsmed 12:188–192
Rehm M, Haller M, Brechtelsbauer H et al (1998) Changes in plasma volume in immediate pre- and postoperative periods in patients with major gynecologic surgery. Infusionsther Transfusionsmed 25:222–228
Rehm M, Orth V, Kreimeier U et al (2000) Changes in intravascular volume during acute normovolemic hemodilution and intraoperative retransfusion in patients with radical hysterectomy. Anesthesiology 92:657–664
Rehm M, Orth VH, Kreimeier U et al (2001) Changes in blood volume during acute normovolemic hemodilution with 5 % albumin or 6 % hydroxyethyl starch and intraoperative retransfusion. Anaesthesist 50:569–579
Rehm M, Orth VH, Weninger E et al (2001) Acute „normovolemic“ hemodilution with 3.5 % polygel (Haemaccel) for patients in the Wertheim-Meigs-operation. Blood loss of 87 % blood volume without perioperative blood transfusion. Anaesthesist 50(8):580–584
Rehm M, Zahler S, Lötsch M et al (2004) Endothelial glycocalyx as an additional barrier determining extravasation of 6 % hydroxyethyl starch or 5 % albumin solutions in the coronary vascular bed. Anesthesiology 100(5):1211–1223
Rehm M, Bruegger D, Christ F et al (2007) Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 116(17):1896–1906
Reid F, Lobo DN, Williams RN et al (2003) (Ab)normal saline and physiological Hartman’s solution: a randomized double-blind crossover study. Clin Sci 104:17–24
Rhee P, Wang D, Ruff P et al (2000) Human neutrophil activation and increased adhesion by various resuscitation fluids. Crit Care Med 28(1):74–78
Rhind SG, Crnko NT, Baker AJ et al (2010) Prehospital resuscitation with hypertonic saline-dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients. J Neuroinflammation 18(7):5
Riddez L, Johnson L, Hahn RG (1998) Central and regional hemodynamics during crystalloid fluid therapy after uncontrolled intra-abdominal bleeding. J Trauma 44(3):433–439
Riddez L, Hahn RG, Brismar B et al (1997) Central and regional hemodynamics during acute hypovolemia and volume substitution in volunteers. Crit Care Med 25(4):635–640
Rivers E, Nguyen B, Havstad S et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345(19):1368–1377
SAFE Study Investigators, Australian and New Zealand Intensive Care Society Clinical Trials Group, Australian Red Cross Blood Service et al (2007) Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 357(9):874–884
Sander-Jensen K, Secher NH, Bie P et al (1986) Vagal slowing of the heart during hemorrhage: observations from 20 consecutive patients. BMJ 292:364–366
Sander-Jensen K, Marving J, Secher NH et al (1990) Does the decrease in heart rate prevent a detrimental decrease of the end systolic volume during central hypovolemia in man? Angiology 41:687–695
Schabinski F, Oishi J, Tuche F et al (2009) Effects of a predominantly hydroxyethyl starch (HES)-based and a predominantly non HES-based fluid therapy on renal function in surgical ICU patients. Intensive Care Med 35(9):1539–1547
Scheingraber S, Rehm M, Sehmisch C, Finsterer U (1999) Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery. Anesthesiology 90(5):1265–1270
Schöchl H, Voelckel W (2010) Die Evidenz der Volumentherapie. „Aggressive“ Volumentherapie heute zunehmend kritisch betrachtet. Wien Klin Mag 13(1):12–14
Schortgen F, Girou E, Deye N et al (2008) The risk associated with hypertonic colloids in patients with shock. Intensive Care Med 34:2157–2168
Secher NH, Sander Jensen K, Werner C et al (1984) Bradycardia during severe but reversible hypovolemic shock in man. Circ Shock 14:267–274
Shoemaker WC, Montgomery ES, Kaplan E, Elwyn DH (1973) Physiologic patterns in surviving and nonsurviving shock patients. Use of sequential cardiorespiratory variables in defining criteria for therapeutic goals and early warning of death. Arch Surg 106(5):630–636
Sossdorf M, Marx S, Schaarschmidt B et al (2009) HES 130/0.4 impairs haemostasis and stimulates pro-inflammatory blood platelet function. Crit Care 13(6):R208
Spahn DR, Bouillon B, Cerny V et al (2013) Management of bleeding following major trauma: an updated European guideline. Crit Care 17(2):R76
Stewart PA (1983) Modern quantitative acid-base chemistry. Can J Physiol Pharmacol 61(12):1444–1461
Struchen MA, Hannay HJ, Contant CF, Robertson CS (2001) The relation between acute physiological variables and outcome on the Glasgow Outcome Scale and Disability Rating Scale following severe traumatic brain injury. J Neurotrauma 18(2):115–125
Swan HJ, Ganz W, Forrester J et al (1970) Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter. N Engl J Med 283:447–451
Traumaregister der Deutschen Gesellschaft für Unfallchirurgie. Jahresbericht 2013 für den Zeitraum bis Ende 2012. http://www.traumaregister.de/images/stories/downloads/jahresberichte/TR-DGU-Jahresbericht_2013.pdf
Vassar MJ, Perry CA, Gannaway WL, Holcroft JW (1991) 7.5 % sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport. Arch Surg 126(9):1065–1072
Victorino GP, Battistella FD, Wisner DH (2003) Does tachycardia correlate with hypotension after trauma? J Am Coll Surg 196(5):679–684
Wakim KG (1970) „Normal“ 0.9 % salt solution is neither „normal“ nor physiological. JAMA 214:1710
Van der Linden P, James M, Mythen M, Weikopf RB (2013) Safety of modern starches used during surgery. Anesth Analg 116(1):35–48
Velmahos GC, Demetriades D, Shoemaker WC et al (2000) Endpoints of resuscitation of critically injured patients: normal or supranormal? A prospective randomized trial. Ann Surg 232(3):409–418
Weiskopf RB, Viele MK, Feiner J et al (1998) Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 279(3):217–221
Wisner DH, Sturm JA (1986) Controversies in the fluid management of post-traumatic lung disease. Injury 17(5):295–300
Wohlauer MV, Moore EE, Droz NM et al (2012) Hemodilution is not critical in the pathogenesis of the acute coagulopathy of trauma. J Surg Res 173(1):26–30
Yunos NM, Bellomo R, Hegarty C et al (2012) Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 308(15):1566–1572
Zander R (2009) Anforderungen an einen optimalen Volumenersatz. Anasth Intensivmed 50:348–357
Zander R (2010) Anaemia and massive bleeding apart from the aspect of oxygenation. Wien Klin Wochenschr 122(Suppl 5):S6–S8
Einhaltung ethischer Richtlinien
Interessenskonflikt. M. Roessler, K. Bode und M. Bauer geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag enthält keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Addendum
Addendum
Am 04.09.2014, zum Zeitpunkt der Drucklegung des vorliegenden Beitrags „Volumentherapie bei Hämorrhagie“ wurde die „S3-Leitlinie Intravasale Volumentherapie beim Erwachsenen“ (AWMF-Register-Nr.: 001/020) veröffentlicht. Die S3-Leitlinie konnte im vorliegenden Beitrag daher nicht berücksichtigt werden. Gleichwohl entsprechen sich die zur Volumentherapie bei Hämorrhagie gemachten Empfehlungen im Wesentlichen. Die S3-Leitlinie zur intravasalen Volumentherapie geht detailliert auf den Stellenwert invasiver Methoden zur Diagnostik eines Volumenmangels, insbesondere auf den Stellenwert statischer, flussbasierter oder dynamischer Vorlastparameter ein. Der Leitthemenbeitrag „Volumentherapie bei Hämorrhagie“ beschränkt sich diesbezüglich im Wesentlichen auf Parameter, die schnell und fast jederzeit erhoben werden können. Der Stellenwert des ZVD ist – auch in der S3-Leitlinie – weiterhin kontrovers.
Die Autoren hoffen, dass der vorliegende Beitrag – zusammen mit der S3-Leitlinie – den interessierten Lesern eine Hilfestellung sein wird, um bei Patienten mit Hämorrhagie eine rational begründbare, sichere und effektive Volumenersatztherapie durchzuführen.
Rights and permissions
About this article
Cite this article
Roessler, M., Bode, K. & Bauer, M. Volumentherapie bei Hämorrhagie. Anaesthesist 63, 730–744 (2014). https://doi.org/10.1007/s00101-014-2377-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00101-014-2377-9